recombinant protein vaccines

recombinant protein vaccines

featured image of Revolutionizing mRNA: A Breakthrough in Biologics!

Revolutionizing mRNA: A Breakthrough in Biologics!

BIOT

🌟 Discover how Ginkgo Bioworks and TriLink BioTechnologies are revolutionizing mRNA manufacturing for better vaccines and therapeutics! 🚀🔬💡

featured image of Wacker Biotech Unveils €100m RNA Manufacturing Site: Creating Jobs and Expanding Expertise!

Wacker Biotech Unveils €100m RNA Manufacturing Site: Creating Jobs and Expanding Expertise!

BIOT

📢 German CDMO Wacker Biotech opens €100m RNA manufacturing site, creating 100 jobs and expanding expertise in RNA active ingredients. 💪🌍

featured image of French Company Receives $6m Grant to Fight Malaria

French Company Receives $6m Grant to Fight Malaria

BIOT

📢 French company Medincell Corp awarded $6m grant by Unitaid to fund safety testing of its malaria vaccine mdc-STM. 🌍🦟

featured image of The High Costs of Low-Quality Albumin: Risks and Solutions

The High Costs of Low-Quality Albumin: Risks and Solutions

BIOT

1. 🚫💉 The Hidden Costs of Sub-standard Recombinant Albumin: Lost batches and patient risks in vaccines and biopharmaceuticals. 💰💊 2. The Hidden Costs of Sub-standard Recombinant Albumin: Safely lowering prices and broadening access to premium albumin. 💡💉🌾🔬🔍

featured image of WHO Launches Biomanufacturing Training to Boost Global Vaccine Production

WHO Launches Biomanufacturing Training to Boost Global Vaccine Production

BIOT

🌍 WHO launches Biomanufacturing Workforce Training Initiative to improve bioproduction in LMICs. 🏭💪🔬 Enhancing local vaccine production and building capacity.

featured image of Revolutionizing Biomanufacturing: Faster Cheaper and More Efficient

Revolutionizing Biomanufacturing: Faster Cheaper and More Efficient

BIOT

🧪 Quick production of therapeutics and vaccines using a disease-agnostic platform approach. 📊 Improved mRNA yields in just two hours. 🖥️ Real-time process monitoring and control. 💉 Billions of vaccine doses produced using a platform process. 🧫 Efficient and cost-effective allogeneic cell therapies. 🌐 Scalable, monitored, and controlled manufacturing of advanced therapies and vaccines. 💡 Future perspective: reducing costs and manufacturing risk with platform-based iPSC production.

featured image of Revolutionary Method Purifies Virus-Like Particles Easily!

Revolutionary Method Purifies Virus-Like Particles Easily!

BIOT

🔬 Malaysian researchers purify virus-like particles (VLPs) without chromatography columns using metal ions, simplifying vaccine production. 💉🌡️🧪💭

featured image of Discover the Versatile Marvel of Albumin

Discover the Versatile Marvel of Albumin

BIOT

💪 Albumin plays a crucial role in the body, from maintaining osmotic pressure to transporting molecules and preventing oxidative damage. 🔬 💊 Its diverse uses in pharmaceuticals, vaccine production, and biomedical coatings make it a valuable resource. 💡 🌍 The global albumin market is expanding, with recombinant albumins leading the way in medical applications. 📈

featured image of Breakthrough Partnership: GSK and Elegen Revolutionize DNA Medicines

Breakthrough Partnership: GSK and Elegen Revolutionize DNA Medicines

BIOT

🔬 GSK teams up with Elegen Bio to develop DNA-based medicines and vaccines, revolutionizing the field of biotechnology. 💉💊

featured image of Supercharge Vaccine Development with Automation and Collaboration

Supercharge Vaccine Development with Automation and Collaboration

BIOT

🧪 Recombinant protein vaccines are safe, effective, and easy to store, making them a leading human vaccine technology. ⏰ Shortening the time from vaccine discovery to commercialization is crucial for better pandemic preparedness. 🤖 Automation and digitalization can speed up vaccine development. 👥 Collaboration and open access platforms can facilitate knowledge sharing and ensure global access to vaccines. 💪 Scalable biotech manufacturing facilities with modular and flexible technologies are essential for large-scale production. 🏭 CDMOs have become crucial in responding to vaccine production demands. 🌍 Ensuring stable supply chains and timely regulatory certifications is necessary for CDMOs.